


Schroders: What next for healthcare investing after Covid vaccine success?
With three Covid-19 vaccines proving effective, we ask fund manager John Bowler and Data Insights Unit head Mark Ainsworth what comes next as regards the pandemic, and what the future holds for healthcare investing.
Schroders: Has the euro's time come to shine?
The stage could be set for a period of strong performance for the euro, thanks in no small part to the EU’s Next Generation policy initiative.
Schroders: What does US-China decoupling mean for emerging markets?
As ties between the world’s superpowers continue to loosen, we look at the implications for investors and the emerging market countries that could benefit.
Schroders: Is sustainable infrastructure the best way to tackle climate change ?
The emerging market need for huge amounts of infrastructure spending must be met sustainably for the planet’s sake - and that’s good news for investors.
Schroders: US economy could face standstill as uncertainty reigns
Keith Wade, Chief Economist, Schroders discusses why stimulus hopes are fading as the result of the US Presidential election remains uncertain
Schroders: Five trends to watch in China’s consumer sector
The near term focus understandably remains on Covid-19 and its global impact. But once the pandemic recedes, the outlook for China’s consumer sector is strong.
Schroders: Sustainable Investment Report Q3 2020
Our sustainable investment team’s latest report includes an update on our engagements and voting, insight into the EU’s Green Deal, and progress on themes such as gender diversity.
Schroders: Why sustainability matters to global cities
Despite a reputation for air pollution and high consumption, global cities can be a force for good in terms of sustainability, as fund manager Tom Walker tells us in this Q&A.
Schroders: What does average inflation targeting mean for investors?
The Federal Reserve has unveiled a new policy framework in the hope of boosting inflation. We assess the implications for bond markets.
Schroders: Microfinance: why grass roots EM investing has proved resilient
As the pandemic unfolded, concerns arose that it could be crippling for some emerging markets, but many have been surprisingly robust. The microfinance experts at BlueOrchard explain why.